Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Cause-Specific Conditional Survival In 2603 Consecutive Patients Undergoing Autologous Hematopoietic Cell Transplantation (aHCT) Over a 20-Year Period

Ari M. Vander Walde, M.D., M.P.H., Can-Lan Sun, Ph.D., Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Neal Kogut, M.D., Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia

Blood (2010) 116 (21): 933.

https://doi.org/10.1182/blood.V116.21.933.933

Published: 2010

Journal Articles

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Lester A. Laddaran, B.A., Can-Lan Sun, Ph.D., Ari M. VanderWalde, MD, MPH, Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Chatchada Karanes, MD, Neil Martin Kogut, MD, Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Margaret O'Donnell, M.D., F.R.C.P.C., Pablo Parker, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia

Blood (2010) 116 (21): 902.

https://doi.org/10.1182/blood.V116.21.902.902

Published: 2010

Journal Articles

Dose Dependent Effect of Deferasirox on Hematopoietic Progeneitors of Myelodysplastic Syndrome

Vinod Pullarkat, Arjun Sehgal, Liang Li, MD, PhD, Allen Lin, Stephen J. Forman, M.D., Ravi Bhatia, MD

Blood (2010) 116 (21): 3994.

https://doi.org/10.1182/blood.V116.21.3994.3994

Published: 2010

Journal Articles

Bifunctional siRNA Design Targeting Non-Hodgkin’s Lymphoma.

Britta Höhn, PhD, Harris S. Soifer, Ph.D., Stephen J. Forman, M.D., John J. Rossi

Blood (2007) 110 (11): 2357.

https://doi.org/10.1182/blood.V110.11.2357.2357

Published: 2007

Journal Articles

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Sahebi Firoozeh, MD, Jeffery R. Schriber, M.D., Ricardo Spielberger, M.D., Ji-Lian Cai, M.D., Neil Martin Kogut, M.D., Peter M. Falk, M.D., Pablo Miguel Parker, M.D., Amrita Krishnan, M.D., Leslie Popplewell, M.D., Chatchada Karanes, M.D., Dajun Qian, PhD., Stephen J. Forman, M.D., George Somlo, M.D.

Blood (2007) 110 (11): 3030.

https://doi.org/10.1182/blood.V110.11.3030.3030

Published: 2007

Journal Articles

Delayed Chronic Kidney Disease (CKD) after Hematopoietic Cell Transplantation (HCT).

Andrea R. Carter, BA, Michael Choi, M.P.H., Can-Lan Sun, Ph.D., Liton Francisco, B.S., Stephen J. Forman, M.D., Smita Bhatia, M.D., M.P.H.

Blood (2006) 108 (11): 552.

https://doi.org/10.1182/blood.V108.11.552.552

Published: 2006

Journal Articles

Early Goal Directed Therapy for Septic Shock Is Feasible and Safe in Hematopoietic Stem Cell Transplant Patients.

Zaid S. Al-Kadhimi, MD, Argelia J. Sandoval, M.D., Jasmine M. Zain, M.D., Stephen J. Forman, M.D.

Blood (2006) 108 (11): 5295.

https://doi.org/10.1182/blood.V108.11.5295.5295

Published: 2006

Journal Articles

Delayed Varicella Zoster Virus (VZV) Infection Following Hematopoietic Cell Transplantation (HCT).

Liton Francisco, BS, Mary Harton, M.P.H., Can-Lan Sun, Ph.D., Andrea R. Carter, B.A., John Zaia, M.D., Stephen J. Forman, M.D., Sanjeet Dadwall, M.D., Smita Bhatia, M.D., M.P.H.

Blood (2006) 108 (11): 3366.

https://doi.org/10.1182/blood.V108.11.3366.3366

Published: 2006

Journal Articles

90 Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose Therapy (HDT) Followed by Autologous Stem Cell Transplant (ASCT) May Improve Survival in Patients with Poor-Risk Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Retrospective Comparative Analysis.

Auayporn P. Nademanee, MD, Amrita Krishnan, M.D, Nicole Tsai, MS, MPH, Joycelynne Palmer, Ph.D., Arturo Molina, M.D., Henry C. Fung, M.D., David Yamauchi, M.D, Neil Martin Kogut, M.D., Stephen J. Forman, M.D., Andrew Raubitschek, M.D.

Blood (2006) 108 (11): 327.

https://doi.org/10.1182/blood.V108.11.327.327

Published: 2006

Journal Articles

Impact of Long-Term Sequelae Diagnosed after Hematopoietic Cell Transplantation (HCT) on Health-Related Quality of Life (HRQL): A Report from the Bone Marrow Transplant Survivor Study.

Can-Lan Sun, PhD, Liton Francisco, B.S., Andrea R. Carter, B.A., K. Scott Baker, M.D., M.S., Marcia Grant, RN, DNSc, FAAN, Daniel J. Weisdorf, M.D., Stephen J. Forman, M.D., Smita Bhatia, M.D., M.P.H.

Blood (2006) 108 (11): 73.

https://doi.org/10.1182/blood.V108.11.73.73

Published: 2006

Journal Articles

The Impact of Disease Status on the Outcome of High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT) for Peripheral T-Cell Lymphoma (PTCL).

Auayporn P. Nademanee, MD, Jasmine M. Zain, M.D., Joycelynne Palmer, Ph.D., Nicole Tsai, M.S., M.P.H., Neil Martin Kogut, M.D., Amrita Krishnan, M.D., Leslie Popplewell, M.D., Roberto Rodriguez, M.D., Eileen Patricia Smith, M.D., Stephen J. Forman, M.D.

Blood (2006) 108 (11): 3060.

https://doi.org/10.1182/blood.V108.11.3060.3060

Published: 2006

Journal Articles

Health-Related Quality of Life (HRQL) in Adult Long-Term Hematopoietic Cell Transplant (HCT) Survivors: A Report from the Bone Marrow Transplant Survivor Study.

Smita Bhatia, M.D., M.P.H., Liton Francisco, B.A., Andrea Carter, B.A., K. S. Baker, M.D., Stephen J. Forman, M.D., James G. Gurney, Ph.D., Leslie L. Robison, Ph.D., Daniel J. Weisdorf, M.D., Marcia Grant, RN, DNSc, FAAN

Blood (2004) 104 (11): 2254.

https://doi.org/10.1182/blood.V104.11.2254.2254

Published: 2004

Journal Articles

Simultaneous Reconstitution of Multiple CMV-Specific CD8 + T-Cell Populations with Divergent Functionality in Hematopoietic Stem Cell Transplant Recipients.

Simon F. Lacey, Ph.D., Joy Martinez, Ghislaine Gallez-Hawkins, Lia Thao, Jeff Longmate, Ph.D., Wahajul Haq, Ph.D., Ricardo Spielberger, M.D., Stephen J. Forman, M.D., John A. Zaia, M.D., Don J. Diamond, Ph.D.

Blood (2004) 104 (11): 190.

https://doi.org/10.1182/blood.V104.11.190.190

Published: 2004

Journal Articles

Evidence of Donor Derived Malignancies Following Hematopoietic Stem Cell Transplantation.

Olga Sala-Torra, M.D., Michael R. Loken, Ph.D., Mary E.D. Flowers, M.D., Paula A. Ladne, M.S., James Mason, M.D, David Senitzer, Ph.D., Stephen J. Forman, M.D., Jerald Radich, M.D.

Blood (2004) 104 (11): 2247.

https://doi.org/10.1182/blood.V104.11.2247.2247

Published: 2004

Journal Articles

A Retrospective Study of Patients Treated with Imatinib Mesylate Prior to Allogeneic Hematopoietic Stem Cell Transplant.

Vivian G. Oehler, M.D., Ted Gooley, David S. Snyder, M.D., Stephen J. Forman, M.D., Jerald P. Radich, M.D.

Blood (2004) 104 (11): 2752.

https://doi.org/10.1182/blood.V104.11.2752.2752

Published: 2004

Journal Articles

Functional Limitations, Physical Disability and Social Competence among HCT Survivors Transplanted during Childhood or Adolescence: A Report from the Bone Marrow Transplant Survivor Study.

Kirsten K. Ness, M.P.H., James G. Gurney, Ph.D., K. S. Baker, M.D., Liton Francisco, B.A., Andrea Carter, B.A., Stephen J. Forman, M.D., Leslie L. Robison, Ph.D., Joseph Rosenthal, M.D., Smita Bhatia, M.D., M.P.H.

Blood (2004) 104 (11): 59.

https://doi.org/10.1182/blood.V104.11.59.59

Published: 2004

NARROW

Cause-Specific Conditional Survival In 2603 Consecutive Patients Undergoing Autologous Hematopoietic Cell Transplantation (aHCT) Over a 20-Year Period

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Dose Dependent Effect of Deferasirox on Hematopoietic Progeneitors of Myelodysplastic Syndrome

Bifunctional siRNA Design Targeting Non-Hodgkin’s Lymphoma.

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Delayed Chronic Kidney Disease (CKD) after Hematopoietic Cell Transplantation (HCT).

Early Goal Directed Therapy for Septic Shock Is Feasible and Safe in Hematopoietic Stem Cell Transplant Patients.

Delayed Varicella Zoster Virus (VZV) Infection Following Hematopoietic Cell Transplantation (HCT).

90 Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose Therapy (HDT) Followed by Autologous Stem Cell Transplant (ASCT) May Improve Survival in Patients with Poor-Risk Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Retrospective Comparative Analysis.

Impact of Long-Term Sequelae Diagnosed after Hematopoietic Cell Transplantation (HCT) on Health-Related Quality of Life (HRQL): A Report from the Bone Marrow Transplant Survivor Study.

The Impact of Disease Status on the Outcome of High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT) for Peripheral T-Cell Lymphoma (PTCL).

Health-Related Quality of Life (HRQL) in Adult Long-Term Hematopoietic Cell Transplant (HCT) Survivors: A Report from the Bone Marrow Transplant Survivor Study.

Simultaneous Reconstitution of Multiple CMV-Specific CD8 + T-Cell Populations with Divergent Functionality in Hematopoietic Stem Cell Transplant Recipients.

Evidence of Donor Derived Malignancies Following Hematopoietic Stem Cell Transplantation.

A Retrospective Study of Patients Treated with Imatinib Mesylate Prior to Allogeneic Hematopoietic Stem Cell Transplant.

Functional Limitations, Physical Disability and Social Competence among HCT Survivors Transplanted during Childhood or Adolescence: A Report from the Bone Marrow Transplant Survivor Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only